Inflammasome sensor NLRP1 disease variant M1184V promotes autoproteolysis and DPP9 complex formation by stabilizing

Jonas Moecking1, Pawat Laohamonthonkul2, Kubilay Meşe1

  • 1Institute of Structural Biology, Medical Faculty, University of Bonn, Bonn, Germany.

Insights

The NLRP1 M1184V variant stabilizes the FIIND domain, promoting NLRP1 multimerization and enhancing binding to DPP9. This explains the variant's role in autoimmune diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Structural Biology

Background:

  • The inflammasome sensor NLRP1 (nucleotide-binding oligomerization domain-like receptor containing a pyrin domain 1) is crucial for innate immunity, initiating inflammatory responses via pyroptosis and cytokine release.
  • NLRP1 mutations are linked to autoinflammatory diseases, highlighting the importance of understanding its regulation.
  • The common NLRP1 M1184V variant is associated with asthma, inflammatory bowel disease, and diabetes.

Purpose of the Study:

  • To investigate the functional impact of the common NLRP1 M1184V variant on protein stability and interactions.
  • To elucidate the molecular mechanisms underlying the association of NLRP1 M1184V with various autoinflammatory conditions.

Main Methods:

  • Size-exclusion chromatography to assess protein conformation.
  • Molecular dynamics simulations to analyze domain flexibility.
  • Surface plasmon resonance and immunoprecipitation assays to determine binding affinities.
  • Enzyme activity assays to evaluate complex formation.

Main Results:

  • The M1184V variant stabilizes the FIIND domain in a monomeric state, independent of autoproteolysis.
  • Valine at position 1184 reduces ZU5 domain flexibility, potentially stabilizing the catalytic triad.
  • Monomeric FIIND domain promotes full-length NLRP1 multimerization.
  • The M1184V variant enhances binding affinity for dipeptidyl peptidase 9 (DPP9) to both FIIND and full-length NLRP1.
  • Increased DPP9 binding was confirmed in cellular models, indicating improved formation of an autoinhibited complex.

Conclusions:

  • The M1184V variant's stabilization of the FIIND domain and enhanced DPP9 binding provide a molecular basis for its involvement in autoimmune syndromes.
  • Understanding NLRP1 variant function is critical for deciphering the pathogenesis of autoinflammatory diseases.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.9K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.8K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.7K